To evaluate reasons for performing ultrasonography (US) and completeness of US reports in patients undergoing endocrine consultation with the rst diagnosis of nodular disease.
MethodsSince January 1 to June 30, 2021, we prospectively collected patient data (age and thyroid-stimulating hormone concentrations), reasons for performing thyroid US, and completeness of reports regarding the description of the thyroid gland and nodules. In the case of multiple nodules, we considered the nodule suspected of malignancy and the largest one. To evaluate the accuracy of thyroid nodule description, we referred to the ve characteristics suggested by the TIRADS system.
ResultsA total of 341 patients with thyroid nodules received endocrine consultation (female, 78%). The most frequent reasons for performing thyroid US were unrelated to a suspected thyroid disease (31.7%), followed by incidentaloma (23.5%), dysfunction or positivity for thyroid antibodies (19.1%), symptomatic or visible nodules (17.6%), and family history (8.2%). Gland texture was not reported in 41.9%. The depth of the lobes was the dimension reported most frequently (42.2%), but the diameter was not reported in 57.8% of the cases. As regards the description of the most relevant nodule, length was reported more frequently (75.9%). Margins and echogenicity were more frequently described (54.5% and 44.3%, respectively) than other characteristics (composition, 27%; echogenic foci, 6.7%; shape, 0.6%). No reports had indicated the malignancy risk strati cation.
ConclusionsThe results of the study demonstrate that in patients undergoing endocrine consultation with rst detected thyroid nodules, US was mostly performed in asymptomatic cases, US reports were incomplete, and no risk strati cation system was reported.